The rounds this investor is named on, who it invests beside, and where it shows up.
Named on one round in the feed.
AVM is the wholly-owned venture capital organization within Astellas, dedicated to supporting pre-clinical, cutting-edge science that can bring VALUE to patients.
Corporate venture arm480 Forbes Blvd, South San Francisco, CA 94080astellasventure.comSince 2026-04-08
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Sidewinder Therapeutics Sidewinder Therapeutics specializes in developing bispecific antibody-drug conjugates aimed at treating difficult cancers for patients. | Series B Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $137M | 2026-04-08 | [ PART ] |
No sector on record.